HLA-DRB1 alleles influence clinical phenotypes in Japanese patients with ulcerative colitis

Y Matsumura1, Y Kinouchi, E Nomura

  • 1Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan. matmat@white.plala.or.jp

Tissue Antigens
|April 18, 2008
PubMed

Insights

Human leukocyte antigen (HLA) associations with ulcerative colitis (UC) in Japanese patients reveal HLA-DRB1*09 links to later diagnosis and HLA-DRB1*08 to extended disease, impacting UC phenotypes.

Area of Science:

  • Immunogenetics
  • Gastroenterology

Background:

  • The human leukocyte antigen (HLA) region is linked to inflammatory bowel disease susceptibility.
  • HLA-DRB1 influences ulcerative colitis (UC) clinical phenotypes in Caucasians.
  • Previous studies identified HLA-DRB1*1502 association with UC in Japanese individuals.

Purpose of the Study:

  • To investigate the association between HLA-DRB1 alleles and clinical phenotypes in Japanese patients with UC.
  • To determine if specific HLA-DRB1 alleles correlate with disease extent, age at diagnosis, or treatment needs in Japanese UC patients.

Main Methods:

  • Genotyping of HLA-DRB1 alleles in 353 Japanese UC patients.
  • Classification of patients based on sex, age at diagnosis, disease extent, and treatment requirements.
  • Statistical analysis to compare allele frequencies across different clinical subgroups.

Main Results:

  • HLA-DRB1*08 allele frequency was significantly higher in patients with extensive UC compared to proctitis (OR=2.20, Pc=0.043).
  • HLA-DRB1*09 allele frequency was significantly higher in patients diagnosed at age 40 or older versus before 40 (OR=2.31, Pc=0.022).
  • No significant associations were found for other subgroups or alleles.

Conclusions:

  • HLA-DRB1*09 is associated with later age at diagnosis in Japanese UC patients.
  • HLA-DRB1*08 is associated with greater disease extent in Japanese UC patients.
  • HLA-DRB1 alleles contribute to both UC susceptibility and clinical phenotype variation in the Japanese population.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...